A 12-year retrospective study of non-burn skin loss (burn-like syndromes) at a tertiary burns unit in a developing country

Burns

Volumn 34, Issue 5, 2008, Pages 637-643

  Ugburo, A O ^a   Temiye, E O ^a   Ilombu, C A ^a  

^a UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

Pemphigus vulgaris; Staphylococal scalded skin; Steven Johnson Syndrome; Toxic epidermal necrolysis

Indexed keywords

ARTEMETHER; AZATHIOPRINE; CEFTRIAXONE; CHLOROQUINE; CHLORPHENIRAMINE; COTRIMOXAZOLE; DERMAZINE; FANSIDAR; HYDROCORTISONE; PREDNISOLONE; SULFADIAZINE SILVER;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CAUSE OF DEATH; CELLULITIS; CHILD; CLINICAL ARTICLE; DEMOGRAPHY; DERMATITIS; DEVELOPING COUNTRY; DRUG HYPERSENSITIVITY; EXFOLIATIVE DERMATITIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERSENSITIVITY; MALE; MEDICAL RECORD; NECROTIZING FASCIITIS; PEMPHIGUS VULGARIS; RETROSPECTIVE STUDY; SKIN DEFECT; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; WHOLE BODY SCINTISCANNING; WOUND;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; BANDAGES; BURN UNITS; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DRUG COMBINATIONS; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; MALE; NIGERIA; PROGNOSIS; PYRIMETHAMINE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL SCALDED SKIN SYNDROME; STEVENS-JOHNSON SYNDROME; SULFADOXINE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 44649087249     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2007.08.022     Document Type: Article

References (22)

1. Atiyeh B.S., Kayle D.I., and Nasser A.A. Burn like syndromes. Ann Burns Fire Disasters 12 (1999) 39-43
2. Brambilla G., Brucato F., Angrisano A., and Palmieri G. Treatment of toxic epidermal necrolysis (TEN). Ann Burns Fire Disasters 15 (2002) 17-21
3. Harris N.J., and Ghosh M. Skin and extremity loss in meningococcal septicemia treated in a burn unit. Burns 20 (1994) 471-472
4. Castana O., Makrodimou M., Michelakis D., Tsandoulas Z., and Alexakis D. Diseases mimicking a burn-outcome and treatment. Ann Burns Fire Disasters 18 (2005) 130-132
5. Fitzpatrick T.B., Johnson R.A., Wolff K., and Suurmond D. Color atlas and synopsis of clinical dermatology common and serious diseases. 4th ed. (2001), McGraw Hill, New York
6. Leaute-Labreze C., Lamireau T., Chawki D., Malevile J., and Taieb A. Diagnosis, classification and management of erythema multiforme and Stevens-Johnsons syndrome. Arch Dis Child 83 (2000) 347-352
7. Jackson R. Sir Jonathan Hutchinson on toxic epidermal necrolysis-an historical note. Br J Dermatol 91 (1974) 469-541
8. Marinkovich MP. Blistering diseases. Department of dermatology, Stanford University School of medicine. http://telemedicine.org/blister.htm.
9. Ruiz-Maldonado R. Acute disseminated epidermal necrosis types 1, 2, and 3: study of sixty cases. J Am Acad Dermatol 13 (1985) 623-625
10. Halebian P.H., Corder V.J., Madden M.R., Finkelstein J.L., and Shires G.T. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 204 (1986) 503-512
11. Riichiro A., Tadamichi S., Akihiko S., Hideki N., Hirokazu W., and Hiroshi S. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol 162 (2003) 1515-1520
12. The United Nations Children's Fund (UNICEF). The State of the World's Children (December 2005), The United Nations Children's Fund, New York. http://www.unicef.org/ [accessed at www.unicef.org]
13. Nga-Shuen L., Yao-Hsu Y., Li-Chieh W., Yu-Tsan L., and Bor-Luen C. Clinical characteristics of childhood erythema multiforme, Stevens-Johnsons syndrome and Toxic epidermal necrolysis in Taiwanese children. J Microbiol Immunol Infect 37 (2004) 366-370
14. Shun-Yuen Y., Waisun H., and Henry H.L.C. Toxic epidermal necrolysis. 10 years experience of a burns centre in Hong Kong. Burns 27 (2001) 372-375
15. Viard I., Wehrli P., Bullani R., SchneiderF P., Holler N., Salmon D., et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282 (1998) 490-493
16. Acikel C., Eren F., Ergun O., and Celikoz B. Topical treatment of toxic epidermal necrolysis using omniderm and glycerol-preserved human cadaver skin. Ann Burns Fire Disasters 15 (2002) 75-78
17. Spies M., Sanford A.P., Aili Low J.F., Wolf S.E., and Herndon D.N. Treatment of extensive toxic epidermal necrolysis in children. Pediatrics 108 (2001) 1162-1168. http://www.pediatrics.org/cgi/content/full/108/5/1162 [accessed June 25, 2006]
18. Paquet P., Jacob E., Damas P., and Pierrard G.E. Treatment of drug-induced toxic epidermal necrolysis (Lyells's syndrome) with intravenous human immunoglobulins. Burns 27 (2001) 652-655
19. Avakian R., Flowers F.P., Araujo O.E., and Ramos-Caro F.A. Toxic epidermal necrolysis: a review. J Am Acad Dermatol 25 (1991) 69-79
20. Smoot E.C. Treatment issues in the care of patients with toxic epidermal necrolysis. Burns 25 (1999) 439-442
21. Napoli B. A propos Lyells Syndrome treatment. Ann Burns Fire Disasters 17 (2004) 162-163 [Letter to the Editor]
22. Nair P.S., Moorthy P.K., and Yogiragan Y. A study of mortality in dermatology. Indian J Dermatol Venereol Leprol 71 (2005) 23-25